[Lipid therapy is effective in concomitant risk. In this way statins can be prescribed in a budget-appropriate manner].
D002017:Budgets; D003362:Cost-Benefit Analysis; D005858:Germany; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000191:economics; D015228:Hypertriglyceridemia / Q000188:drug therapy* / Q000191:economics; D011725:Pyridines / Q000191:economics / Q000627:therapeutic use*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; C086276:cerivastatin